Table 2.
Test | Cases, % (No.) | Controls, % (No.) | P Value | Adjusted OR (95% CI) |
---|---|---|---|---|
KIR2DL1 | 96.3 (313) | 96.9 (1264) | .48 | 1.37 (.57–3.27) |
KIR2DL2 | 51.7 (168) | 50.1 (654) | .89 | 1.02 (.76–1.37) |
KIR2DL3 | 88.6 (288) | 91.7 (1197) | .97 | 1.01 (.59–1.72) |
KIR2DL5 | 53.2 (173) | 46.2 (603) | .27 | 1.18 (.88–1.59) |
KIR2DP1 | 96.3 (313) | 96.9 (1264) | .48 | 1.37 (.57–3.27) |
KIR2DS1 | 42.2 (137) | 36.3 (474) | .09 | 1.30 (.96–1.76) |
KIR2DS2 | 52.6 (171) | 50.6 (660) | .78 | 1.04 (.78–1.40) |
KIR2DS3 | 31.1 (101) | 24.7 (322) | .17 | 1.26 (.91–1.76) |
KIR2DS4 | 35.4 (115) | 39.1 (511) | .84 | 0.97 (.71–1.32) |
KIR2DS5 | 33.2 (108) | 29.7 (388) | .14 | 1.27 (.93–1.74) |
KIR3DL1 | 96.0 (312) | 95.6 (1248) | .49 | 1.31 (.60–2.85) |
KIR3DS1 | 41.8 (136) | 36.2 (473) | .07 | 1.32 (.98–1.79) |
KIR3DS1_hmz | 4.0 (13) | 4.4 (57) | .49 | 0.76 (.35–1.66) |
HLA-A*3/11 | 30.8 (100) | 35.6 (422) | .19 | 0.81 (.59–1.11) |
HLA-A*3/11 + KIR2DS4 | 10.5 (34) | 14.7 (175) | .08 | 0.65 (.41–1.06) |
HLA*Bw4 | 66.0 (210) | 60.5 (711) | .38 | 1.15 (.84–1.57) |
HLA*Bw4 80I | 30.2 (96) | 21.9 (258) | .78 | 0.95 (.66–1.36) |
HLA*Bw4 + KIR3DL1 | 63.2 (201) | 58.2 (684) | .31 | 1.17 (.86–1.60) |
HLA*Bw4 80I + KIR3DS1 | 11.6 (37) | 7.7 (91) | .90 | 0.97 (.55–1.69) |
HLA group C1 | 81.8 (265) | 88.7 (758) | .13 | 0.71 (.46–1.10) |
HLA group C1 hmz + KIR2DL3 hmz | 16.4 (53) | 20.7 (177) | .05 | 0.65 (.43–.99) |
HLA group C2 | 66.0 (214) | 56.0 (479) | .006 | 1.58 (1.14–2.20) |
HLA group C2 hmz + KIR2DL3 hmz | 7.7 (25) | 5.6 (48) | .75 | 1.10 (.59–2.06) |
HLA group C2 + KIR2DL1 | 63.6 (206) | 53.9 (461) | .002 | 1.68 (1.21–2.32) |
HLA group C2 + KIR2DS1 | 26.9 (87) | 20.0 (171) | .03 | 1.51 (1.05–2.17) |
Only the functional KIR2DS4 allele was included. ORs were corrected for population stratification. An OR of >1 reflects protection against HIV infection, and an OR of <1 reflects susceptibility to HIV infection. None of the variables shown here reached the threshold of significance (P = .0006).
Abbreviations: CI, confidence interval; hmz, homozygous; OR, odd ratio.